Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
AOD 9604 primarily affects pathways associated with lipid metabolism, including 3-adrenergic receptor signaling, cyclic AMPmediated cascades, and enzyme systems involved in lipolysis and lipogenesis
Overall, the study demonstrated that AOD9604 affects metabolic parameters in both lean and obese mice, as well as in genetically modified mouse models lacking 3-adrenergic receptors
Research interest around TB-500 often focuses on tissue remodelling, cellular movement, and inflammatory signalling in experimental models
Two are FDA-approved specifically as injectable weight loss medications: Saxenda (liraglutide) approved in 2014, injected once daily
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
